CytoSorbents (CSTO) Presents At BIO CEO & Investor Conference - Slideshow

HELPING REDUCE DEADLY UNCONTROLLED INFLAMMATION IN HOSPITALIZED PATIENTS WORLDWIDE | --- | --- | --- | --- | |-------|-------|--------------|----------------------------------------------------------------| | | | | | | | | NASDAQ: CTSO | Dr. Phillip Chan, MD, PhD - CEO BIO CEO & Investor Conference | Safe Harbor Statement This presentation contains "forward-looking statements" pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, ...